SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-096519
Filing Date
2023-04-10
Accepted
2023-04-10 16:05:30
Documents
14
Period of Report
2023-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d470097d8k.htm   iXBRL 8-K 36677
2 EX-3.1 d470097dex31.htm EX-3.1 14587
3 EX-10.1 d470097dex101.htm EX-10.1 32184
  Complete submission text file 0001193125-23-096519.txt   223136

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bioc-20230410.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bioc-20230410_lab.xml EX-101.LAB 17981
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bioc-20230410_pre.xml EX-101.PRE 11259
8 EXTRACTED XBRL INSTANCE DOCUMENT d470097d8k_htm.xml XML 3473
Mailing Address 9955 MESA RIM ROAD SAN DIEGO CA 92121
Business Address 9955 MESA RIM ROAD SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 800943522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36284 | Film No.: 23811183
SIC: 8071 Services-Medical Laboratories